Inhibition of ESCRT-III activates alternative pathways for protein degradation and secretion

Masaru Fujiwara1, Ryohei Sakai2, Masayuki Takahashi2

  • 1Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8502, Japan; Department of Biotechnology and Life Science, Faculty of Technology, Tokyo University of Agriculture and Technology, 2-24-16 Naka-machi, Koganei, Tokyo, 184-8588, Japan.

Insights

Endosomal sorting complex (ESCRT)-III dysfunction impairs autophagy but enhances protein clearance via alternative pathways. This unexpected clearance, independent of macroautophagy, may contribute to neurological disease pathogenesis.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Molecular Biology

Background:

  • Mutations in ESCRT-III components (e.g., CHMP2B, VPS4A/B) are linked to neurological disorders like FTLD.
  • ESCRT-III's role in intracellular protein degradation, particularly its impact on autophagy, remains incompletely understood.

Purpose of the Study:

  • To investigate the effects of ESCRT-III dysfunction on intracellular protein clearance mechanisms.
  • To determine if ESCRT-III inhibition impacts autophagy and other protein degradation pathways.

Main Methods:

  • Genetic manipulation using a dominant-negative VPS4 form and an FTLD-associated CHMP2B mutant.
  • Assessment of protein clearance in various cell types, including ATG13/ATG5-knockout cells.
  • Analysis of lysosomal substrate accumulation and extracellular vesicle-independent protein secretion.

Main Results:

  • ESCRT-III inhibition suppressed macroautophagic flux but paradoxically promoted protein clearance.
  • Protein clearance occurred independently of macroautophagy, suggesting alternative pathways.
  • Increased lysosomal accumulation of substrate proteins indicated microautophagy activation.
  • Enhanced extracellular vesicle-independent protein secretion and cell-to-cell tau transmission were observed.

Conclusions:

  • ESCRT-III dysfunction impairs canonical autophagy but activates alternative protein degradation and secretion pathways.
  • These alternative pathways, including microautophagy-like processes, may play a role in the pathogenesis of neurological disorders.
  • Understanding these compensatory mechanisms is crucial for developing therapeutic strategies for ESCRT-III-related diseases.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
7.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
7.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K